Mereo BioPharma Group plc (MAH0) — Financial Flexibility Index
Mereo BioPharma Group plc (MAH0) has a Financial Flexibility Index of -1.54x as of December 2025. Free cash flow of €-7.68 Million (operating CF €-7.68 Million minus capex €0.00) represents -2% of total liabilities (€5.00 Million). Check Mereo BioPharma Group plc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mereo BioPharma Group plc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Mereo BioPharma Group plc across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Mereo BioPharma Group plc.
Annual Financial Flexibility Index for Mereo BioPharma Group plc (2016–2025)
Year-by-year free cash flow to debt coverage for Mereo BioPharma Group plc. Explore Mereo BioPharma Group plc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.13x | €-30.65 Million | €-30.97 Million | €5.00 Million | ▼ -194.1% |
| 2024 | -2.08x | €-32.13 Million | €-32.83 Million | €15.42 Million | ▼ -60.6% |
| 2023 | -1.30x | €-20.71 Million | €-21.13 Million | €15.96 Million | ▲ +12.4% |
| 2022 | -1.48x | €-38.81 Million | €-38.82 Million | €26.21 Million | ▼ -1109.2% |
| 2021 | -0.12x | €-4.70 Million | €-5.24 Million | €38.41 Million | ▲ +66.3% |
| 2020 | -0.36x | €-28.32 Million | €-28.34 Million | €77.92 Million | ▲ +63.4% |
| 2019 | -0.99x | €-45.91 Million | €-45.93 Million | €46.19 Million | ▼ -48.4% |
| 2018 | -0.67x | €-23.11 Million | €-23.14 Million | €34.51 Million | ▲ +29.5% |
| 2017 | -0.95x | €-32.13 Million | €-32.15 Million | €33.85 Million | ▲ +76.0% |
| 2016 | -3.95x | €-29.66 Million | €-29.66 Million | €7.51 Million | — |